Chinese companies account for only a tiny percentage of ESG-filtered emerging market ETFs, even though China is 26.5% of the MSCI EM Index.
Tag: MSCI
Equities are at a record high – is this the right time to buy in?
The MSCI World keeps breaking records, powered by a seemingly unstoppable US equity rally. Is it a good idea to up your allocation when markets are at a record high, or should you take a contrarian stance?
European equities hit record high, thanks to small caps
The overall European equity market hit a record high this week, thanks to the mid and small cap segment of the index.
Value factor shines as past winners turn into losers
Value stocks were the stellar performers in all equity markets in 2016. The three factors that had shown most outperformance in recent years, however, disappointed investors last year.
Is large cap focus a problem for ESG trackers?
Passive ESG strategies tend to focus exclusively on large caps. This is a problem because they miss out on ESG opportunities in small cap companies that can only be exploited by active managers, according to Ryan Smith, head of ESG research at Kames Capital. Does he have a point?
Fund buyers uncertain about macro outlook
European investors are more uncertain about their macroeconomic outlook than ever before. In a year’s time, the share of fund buyers with an uncertain macroeconomic outlook has doubled to 60% according to Expert Investor data.
MSCI tells China ‘No for now’
For the third time since 2013, the US index provider rejected the inclusion of China A-shares in its flagship emerging market indices, highlighting key unresolved issues.
A-share inclusion to erode EM equity differentiation
China is so dominant that when A-shares are eventually included in the MSCI Emerging Markets Index, the result could be a spate of very similar passive products.
Is it time to redefine the EM equity categories
Is the MSCI Emerging Markets Index in need of a shake-up?
Is it time to re-draw the EM categories
MSCI’s recent decision to remove South Korea and Taiwan from its review list and exclude China’s A-shares from its EM index raises a few questions about how we should be thinking about emerging markets.
